Depletion rate of blood eosinophils with mepolizumab, benralizumab and oral prednisolone in patients with severe asthma
Hauptverfasser: | , , , , , , , , |
---|---|
Format: | Conference item |
Sprache: | English |
Veröffentlicht: |
European Respiratory Society
2020
|